Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -17.15%314.05M | -18.26%248.98M | -18.45%209.47M | -5.89%1.12B | -18.66%177.44M | -8.03%379.08M | -1.86%304.58M | 3.88%256.85M | 33.62%1.19B | 13.56%218.16M |
Operating revenue | -17.15%314.05M | -18.26%248.98M | -18.45%209.47M | -5.89%1.12B | -18.66%177.44M | -8.03%379.08M | -1.86%304.58M | 3.88%256.85M | 33.62%1.19B | 13.56%218.16M |
Cost of revenue | -16.16%126.42M | -16.04%119.33M | -14.82%105.74M | -7.92%519.65M | -11.85%102.61M | -13.40%150.79M | -6.55%142.13M | 1.95%124.13M | 28.05%564.37M | 7.48%116.4M |
Gross profit | -17.81%187.63M | -20.19%129.65M | -21.84%103.73M | -4.05%598.3M | -26.46%74.84M | -4.11%228.29M | 2.65%162.45M | 5.75%132.72M | 39.10%623.58M | 21.42%101.76M |
Operating expense | -25.46%133.05M | -16.01%143.45M | -10.84%159.59M | -11.93%678.63M | -15.93%150.37M | -19.69%178.48M | -9.41%170.8M | -1.06%178.98M | 34.31%770.54M | -6.90%178.85M |
Selling and administrative expenses | -19.38%62.07M | -12.14%63.93M | -14.46%71.18M | -17.17%293.88M | -18.11%60.92M | -27.41%76.99M | -20.45%72.76M | 0.43%83.21M | 28.20%354.79M | -27.35%74.4M |
-Selling and marketing expense | -30.73%39.94M | -23.50%43.14M | -14.02%49.44M | -14.12%212.27M | -19.00%40.71M | -23.14%57.66M | -9.38%56.4M | -3.61%57.5M | 31.54%247.17M | -31.39%50.26M |
-General and administrative expense | 14.48%22.13M | 27.02%20.79M | -15.46%21.73M | -24.17%81.61M | -16.27%20.21M | -37.74%19.33M | -44.03%16.37M | 10.80%25.71M | 21.15%107.62M | -17.23%24.14M |
Research and development costs | -40.33%9.56M | 6.63%16.64M | 7.24%15.31M | -11.04%60.8M | -6.00%14.9M | -13.01%16.03M | -5.48%15.6M | -18.74%14.27M | 40.31%68.34M | -10.82%15.85M |
Depreciation amortization depletion | -66.01%6.96M | -73.82%5.39M | -36.56%13.12M | -6.11%78.25M | -20.97%16.51M | -1.90%20.47M | 0.90%20.58M | -2.34%20.69M | 36.01%83.34M | 17.52%20.89M |
-Depreciation and amortization | -66.01%6.96M | -73.82%5.39M | -36.56%13.12M | -6.11%78.25M | -20.97%16.51M | -1.90%20.47M | 0.90%20.58M | -2.34%20.69M | 36.01%83.34M | 17.52%20.89M |
Other operating expenses | -16.21%54.46M | -7.04%57.49M | -1.36%59.98M | -6.95%245.71M | -14.29%58.04M | -15.45%65M | 2.79%61.85M | 2.55%60.81M | 41.22%264.07M | 25.06%67.72M |
Operating profit | 9.59%54.59M | -65.40%-13.8M | -20.74%-55.85M | 45.34%-80.34M | 2.02%-75.54M | 214.58%49.81M | 72.45%-8.35M | 16.50%-46.26M | -17.19%-146.96M | 28.82%-77.09M |
Net non-operating interest income expense | -164.43%-1.15M | -51.26%734K | -67.25%280K | 881.88%4.57M | 179.61%425K | 933.53%1.79M | 545.56%1.51M | 249.48%855K | 98.15%-585K | 100.68%152K |
Non-operating interest income | -25.93%1.74M | -44.53%1.16M | -48.99%805K | 252.64%7.02M | 29.57%999K | 201.54%2.35M | 419.85%2.1M | 4,052.63%1.58M | 5,430.56%1.99M | 19,175.00%771K |
Non-operating interest expense | 415.51%2.89M | -27.33%428K | -27.39%525K | -5.01%2.45M | -7.27%574K | -7.43%561K | -20.51%589K | 18.52%723K | -91.88%2.58M | -97.25%619K |
Other net income (expense) | 101.01%4.6M | -92.64%119K | -3,990.77%-83.92M | -145.61%-450.89M | 100.23%518K | -1,978,930.43%-455.18M | -96.03%1.62M | 156.18%2.16M | -5,696.98%-183.58M | -1,769.86%-225.08M |
Special income (charges) | --0 | --0 | ---84M | -87.30%-457M | --0 | ---457M | --0 | --0 | ---243.99M | ---243.99M |
-Less:Impairment of capital assets | --0 | --0 | --84M | 87.30%457M | --0 | --457M | --0 | --0 | --243.99M | --243.99M |
Other non- operating income (expenses) | 152.22%4.6M | -92.64%119K | -96.48%76K | -89.88%6.12M | -97.26%518K | 8,026.09%1.82M | -96.03%1.62M | 156.18%2.16M | 1,741.77%60.41M | 40.30%18.91M |
Income before tax | 114.38%58.03M | -147.96%-12.95M | -222.55%-139.5M | -59.05%-526.65M | 75.30%-74.59M | -2,625.06%-403.58M | -151.99%-5.22M | 21.56%-43.25M | -115.29%-331.13M | -157.43%-302.02M |
Income tax | -9.17%-1.23M | -64.92%147K | 290.63%1.42M | 55.19%1.59M | 3,878.43%1.93M | -760.59%-1.12M | 319.00%419K | -54.79%363K | 30.36%1.02M | -105.93%-51K |
Net income | 114.72%59.26M | -132.15%-13.1M | -223.11%-140.92M | -59.03%-528.23M | 74.66%-76.52M | -2,645.11%-402.46M | -156.73%-5.64M | 22.04%-43.61M | -114.86%-332.15M | -155.51%-301.97M |
Net income continuous Operations | 114.72%59.26M | -132.15%-13.1M | -223.11%-140.92M | -59.03%-528.23M | 74.66%-76.52M | -2,645.11%-402.46M | -156.73%-5.64M | 22.04%-43.61M | -114.86%-332.15M | -155.51%-301.97M |
Minority interest income | 110.22%17.81M | -68.46%-4.25M | -178.67%-55.23M | -48.80%-229.53M | 76.28%-32.92M | -2,426.96%-174.27M | -151.41%-2.52M | 28.85%-19.82M | -1,128.31%-154.25M | -1,005.17%-138.79M |
Net income attributable to the parent company | 118.16%41.45M | -183.60%-8.85M | -260.13%-85.68M | -67.91%-298.7M | 73.28%-43.6M | -2,841.37%-228.19M | -161.90%-3.12M | 15.28%-23.79M | -25.25%-177.9M | -54.50%-163.18M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | ||||||||
Net income attributable to common stockholders | 118.16%41.45M | -183.60%-8.85M | -260.13%-85.68M | -67.91%-298.7M | 73.28%-43.6M | -2,841.37%-228.19M | -161.90%-3.12M | 15.28%-23.79M | -1,301.10%-177.9M | -1,185.21%-163.18M |
Basic earnings per share | 112.08%2.22 | -126.92%-0.59 | -216.42%-6.36 | -53.77%-24.48 | 76.13%-3.48 | -2,616.44%-18.37 | -165.00%-0.26 | 22.69%-2.01 | -1,249.15%-15.92 | -1,115.00%-14.58 |
Diluted earnings per share | 111.43%2.1 | -126.92%-0.59 | -216.42%-6.36 | -53.77%-24.48 | 76.13%-3.48 | -2,651.39%-18.37 | -165.00%-0.26 | 22.69%-2.01 | -1,249.15%-15.92 | -1,115.00%-14.58 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |